State consumer health data and privacy laws: outlook to 2027
Health data outside HIPAA is now regulated state by state, with Washington's private right of action, Connecticut's enforcement and New York's second bill setting the pace.
The question for 2027
Health information collected outside the doctor's office, by apps, wearables, websites, retailers and data brokers, is now regulated state by state, and the rules reach further into hospitals and insurers than their HIPAA compliance programs assume. Washington and Nevada passed stand-alone consumer health data laws in 2023 [1] [6], Connecticut and Maryland wrote health data rules into their general privacy acts [7] [15], Vermont follows from 2028 [17], and New York's legislature has now passed a health information privacy bill twice [10] [11]. This outlook sets out where each strand stands today, how the HIPAA exemptions decide who is caught, what the Federal Trade Commission adds, and what is likely to change through 2027.
Washington: the law with a private right of action
The Washington My Health My Data Act, chapter 19.373 RCW, says in its findings that HIPAA covers only health data collected by specific health care entities and that data collected by apps and websites gets no such protection [1]. It applies to any entity that does business in Washington or targets its consumers, including small businesses, and its main duties began on March 31, 2024 for regulated entities and June 30, 2024 for small businesses [1]. The Attorney General's guidance adds that the geofencing ban, section 10 of the act, applied to all persons from July 23, 2023 [3].
The duties are strict by the standard of other privacy laws. Collection needs consent for a specified purpose and sharing needs separate consent, unless the data is necessary to provide a product or service the consumer asked for; a sale needs a signed authorization separate from either consent; and geofences around in-person health care providers are banned when used to track consumers, collect their health data or send them health-related messages or ads, with a geofence defined as a boundary of 2,000 feet or less [1].
What sets Washington apart is enforcement. RCW 19.373.090 declares every violation an unfair or deceptive act under the Consumer Protection Act, chapter 19.86 RCW [1]. That act lets a person injured in their business or property sue for actual damages and attorney's fees, and lets a court raise the award up to three times actual damages, with the increased award capped at $25,000 for this kind of violation [2]. The Attorney General's guidance confirms the law is enforced by the Attorney General as well as through private action [3]. As of November 16, 2026 we found no enforcement action announced by the Attorney General under the act. Its joint audit committee must report the number of settlements, the average settlement amount and complaint categories, with recommendations, by September 30, 2030 [4].
Nevada and Connecticut: the same duties, enforced by the state
Nevada's Senate Bill 370 took effect on March 31, 2024 [6] and is codified at NRS 603A.400 to 603A.550 [5]. It bans geofences within 1,750 feet of medical facilities and other in-person health care providers [5]. Violations are deceptive trade practices, and NRS 603A.550 says the law creates no private right of action [5].
Connecticut put its rules in section 42-526 of its Data Privacy Act: no person may sell consumer health data without consent, give processors access without a compliant contract, or use a geofence within 1,750 feet of a mental health or reproductive or sexual health facility [7]. The Attorney General's 2025 enforcement report says these provisions apply to all consumer health data controllers doing business in the state regardless of size, and that the office opened an investigation of a hormonal fertility tracker app, testing it on iOS and Android to review data flows [9]. Amendments in force since July 1, 2026 extend the whole act to any business that processes sensitive data, whatever its volume, which the report calls unique to Connecticut [9]. The office's first resolved enforcement action under the act, with TicketNetwork, involved a privacy notice, not health data, and carried an $85,000 payment [9].
Moraph's view
Moraph's view: Connecticut is the state most likely to produce the first public state resolution about consumer health data outside Washington's courts. It reported an ongoing investigation of a fertility tracker app in February 2026, has a dedicated privacy section and a law that since July 2026 reaches every business processing health data. Nevada has the same duties on paper but no comparable public record of enforcement priorities.
New York: vetoed once, passed again
The New York Health Information Privacy Act, S929, passed the Senate on January 21, 2025 and the Assembly on January 22, 2025, was delivered to the Governor on December 8, 2025 and was vetoed on December 19, 2025 (veto memo 135) [10]. Its successor, S9269, was introduced on February 20, 2026, passed the Senate on June 3, 2026 and the Assembly on June 4, 2026 [11]. As checked on November 16, 2026, the Senate's page shows no delivery to the Governor [11].
The bill text makes the sale of regulated health information unlawful, lets only the Attorney General enforce, with civil penalties of not more than $15,000 per violation, and says the act takes effect 6 months after it becomes law [12]. It exempts HIPAA covered entities, and business associates to the extent they handle the information as HIPAA requires [12].
Moraph's view
Moraph's view: the revised bill narrows the first version, for example by exempting HIPAA covered entities outright rather than only to the extent they treat the information as protected health information, and by dropping the alternative penalty measured as a share of New York revenue [10] [12]. Like the first version, it leaves enforcement to the Attorney General. A New York governor can also sign a bill subject to agreed chapter amendments rather than veto it. We think enactment by the end of 2027 is slightly more likely than not; because the act takes effect 6 months after it becomes law, any New York law would apply no earlier than mid-2027.
Comprehensive privacy laws: health as sensitive data, with new dates
Maryland's Online Data Privacy Act goes furthest: a controller may collect, process or share sensitive data only where strictly necessary to provide a product or service the consumer requested, and may not sell it at all [15]. Maryland applies to businesses that controlled or processed the personal data of at least 35,000 consumers in the prior calendar year, or of at least 10,000 consumers while deriving more than 20% of gross revenue from selling personal data [13], and for violations on or before April 1, 2027 the state's Division of Consumer Protection may give at least 60 days to cure [16].
New dates arrive through 2028. Oklahoma's Senate Bill 546 was approved by the Governor on March 20, 2026 [19] and takes effect January 1, 2027 [18]. Alabama's HB 351 was signed by the Governor on April 16, 2026 as Act 2026-552 [28]; it treats a mental or physical health condition or diagnosis as sensitive data and takes effect May 1, 2027 [20]. Vermont's Act 145, signed June 16, 2026, takes effect January 1, 2028; it adds consumer health data rules including a geofencing ban within 1,850 feet of health care facilities, gives no private right of action, and records the General Assembly's intent that the Legislature may consider adding one if the Attorney General is not given resources to enforce [17].
| Law | Health data rule | HIPAA exemption | Consumers may sue |
|---|---|---|---|
| Washington, ch. 19.373 RCW [1] | Consent to collect and to share; signed authorization to sell [1] | Data-level: protected health information and intermingled data [1] | Yes, through the Consumer Protection Act [1] [2] |
| Nevada, NRS 603A.400 to .550 [5] | Geofencing within 1,750 feet banned [5] | Entity-level for anyone subject to HIPAA [5] | No [5] |
| Connecticut, § 42-526 [7] | Consent to sell; applies regardless of size [7] [9] | Entity-level for covered entities and business associates [7] | No [7] |
| Maryland, §§ 14-4701 et seq. [13] | Strict necessity; no sale [15] | Data-level only [13] [14] | No; the Consumer Protection Act's private action, § 13-408, is excluded [29] |
| Vermont, Act 145 (from January 1, 2028) [17] | Consumer health data rules; geofencing within 1,850 feet banned [17] | Entity-level for covered entities that are not hybrid entities, health care components of hybrid entities and business associates [17] | No [17] |
| New York, S9269 (passed, not delivered) [11] | Sale unlawful [12] | Covered entities and conforming business associates [12] | No; Attorney General only [12] |
Where HIPAA stops: why hospitals and insurers are not out of scope
The HIPAA exemptions come in two shapes, and the shape decides whether a health system is in or out. Nevada's exempts any person or entity subject to HIPAA [5]. Washington's exempts information: protected health information, and information that originates from and is intermingled with it at a covered entity, business associate or health care provider [1]. Maryland's list of exempt entities includes financial institutions and certain nonprofits but no HIPAA covered entities [14]; it exempts protected health information, and Maryland medical records held by a HIPAA covered entity or business associate only where the entity applies HIPAA's standards to them [14].
Under a data-level exemption, the parts of a hospital or health plan that sit outside the designated record set are exposed: marketing lists, website and app analytics, wellness programs, event registrations and data about people who are not yet patients. California shows how this plays out. In July 2025 its Attorney General announced a $1.55 million settlement with a health information publisher, alleging that sharing article titles suggesting a reader had been diagnosed with a condition, in order to target advertising, broke the CCPA's purpose limitation, and banning that sharing [27].
Moraph's view
Moraph's view: the exposure for health systems is the marketing and digital front door, not the electronic health record. A hospital that treats its HIPAA program as its privacy program will miss tracking on symptom-checker pages, appointment funnels and apps run by non-covered affiliates in Washington and Maryland. Insurers face the same question for wellness and lead-generation data.
The federal layer: the FTC's breach rule for apps
The FTC's amended Health Breach Notification Rule, published May 30, 2024 and effective July 29, 2024, covers vendors of personal health records and related entities that are not covered by HIPAA [21]. The current text says a breach of security includes unauthorized acquisition that results from an unauthorized disclosure, so sharing data with an advertising partner without authorization can be a breach [22]. Notice to individuals is due without unreasonable delay and no later than 60 calendar days after discovery, and notice to the FTC for breaches of 500 or more people is due at the same time [22]. The FTC's guidance names health apps and connected devices as covered and HIPAA-covered entities such as hospitals and insurers as outside the rule [23].
The enforcement record is short. The FTC called its February 2023 action against GoodRx, with a $1.5 million civil penalty, its first under the rule [24], and its May 2023 action against the developer of the Premom ovulation tracking app, with a $100,000 civil penalty, its second [25]. On September 9, 2026 the Commission rescinded its 2021 Policy Statement on Breaches by Health Apps and Other Connected Devices, saying the 2024 update to the rule, which covers health apps and connected devices, had made it unnecessary [26]; the amended rule itself remains in the current Code of Federal Regulations [22]. We found no action under the rule announced since the 2024 amendments.
What to watch in 2027
Four markers will show which way the field moves: whether New York's S9269 is delivered and signed; whether Connecticut's fertility app investigation produces a public resolution [9]; Oklahoma's and Alabama's effective dates on January 1 and May 1, 2027 [18] [20]; and the end of Maryland's discretionary notice-and-cure period, which covers only violations on or before April 1, 2027 [16]. Federal privacy legislation that would preempt these laws is not among them; we found no bill near enactment.
What this means for you
- Health systems: Map which data sits outside protected health information: website and app analytics, marketing lists and data on prospective patients. Washington and Maryland exempt data, not the hospital [1] [14], and California has penalized sharing diagnosis-revealing page titles for advertising [27].
- Health plans and insurers: Check affiliates and wellness or lead-generation programs that are not HIPAA covered entities against Washington's law, which also exempts data governed by the insurance commissioner's privacy rules [1], and against Connecticut's act, which since July 1, 2026 covers any business processing sensitive data [9].
- Health and wellness apps: Treat advertising and analytics sharing as a possible breach under the FTC rule [22] and as a sale or share needing consent or authorization in Washington [1]; in Washington a person injured in their business or property can sue under the Consumer Protection Act [2].
- Public agencies: Washington's law does not apply to government agencies or contractors processing for them [1], and Maryland excludes state bodies [14]; agency vendors that also sell to consumers should still check their commercial lines.
Moraph predictions
Every prediction is Moraph's view, not a fact. Each has a date, a confidence level (70% means we expect to be wrong about three times in ten) and a test anyone can apply. We score them on this page when the date comes and never remove one. How we make and score predictions.
P1 By Confidence 55% Open
New York enacts a consumer health information privacy law (S9269 of 2026 or a successor bill) on or before December 31, 2027.
How we will check: The New York State Senate bill page for S9269, or for a successor health information privacy bill, shows it signed by the Governor and assigned a chapter number on or before December 31, 2027.
Basis: S929 passed both houses and was vetoed on December 19, 2025 [10]; S9269 passed the Senate on June 3, 2026 and the Assembly on June 4, 2026 and had not been delivered to the Governor as checked [11]; the revised text leaves enforcement to the Attorney General and exempts HIPAA covered entities [12].
P2 By Confidence 85% Open
Washington's My Health My Data Act still makes violations enforceable by private action under the Consumer Protection Act on December 31, 2027.
How we will check: RCW 19.373.090 on the Washington State Legislature's site, as it stands on December 31, 2027, still declares a violation an unfair or deceptive act for the purpose of applying chapter 19.86 RCW, and no law enacted by then removes the private action.
Basis: RCW 19.373.090 applies the Consumer Protection Act to every violation [1], which lets injured persons sue [2]; the Legislature has scheduled its own review of enforcement for September 30, 2030 [4].
P3 By Confidence 55% Open
The Connecticut Attorney General announces a settlement, assurance of voluntary compliance or lawsuit that concerns consumer health data under the Connecticut Data Privacy Act on or before December 31, 2027.
How we will check: A Connecticut Attorney General press release or annual CTDPA enforcement report, dated on or before December 31, 2027, describing a resolved or filed matter that cites the act's consumer health data or sensitive data provisions in connection with health data.
Basis: The 2025 enforcement report describes an ongoing investigation of a hormonal fertility tracker app and a notice of violation to a data broker processing consumer health data [9]; the office resolved its first enforcement action under the act in 2025 [8].
P4 By Confidence 60% Open
The FTC announces no new enforcement action alleging a violation of the Health Breach Notification Rule between November 16, 2026 and December 31, 2027.
How we will check: No FTC press release, complaint or proposed order dated from November 16, 2026 to December 31, 2027 alleges a violation of 16 CFR Part 318.
Basis: The actions the FTC called its first and second under the rule date from February and May 2023 [24] [25]; in September 2026 it rescinded its 2021 health app policy statement as unnecessary after the 2024 update [26], and the amended rule remains in the current text [22].
P5 By Confidence 65% Open
The Washington Attorney General announces no enforcement action brought under chapter 19.373 RCW on or before December 31, 2027.
How we will check: No Washington Attorney General news release or court filing by the office, dated on or before December 31, 2027, announces a lawsuit, consent decree or settlement alleging a violation of chapter 19.373 RCW.
Basis: We found no Attorney General action under the act announced as of November 16, 2026, though the main duties have applied since March 31, 2024 [1] and the Attorney General's guidance says the office enforces the act through the Consumer Protection Act [3], and private plaintiffs can enforce the act through the Consumer Protection Act [2].
Facts on this page link to their sources. Text marked "Moraph's view", and every prediction, is our own analysis, not a fact or advice. Methodology.
Spotted an error? Tell us and we will check it and correct the piece where needed.